Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
D000328:Adult; D000368:Aged; D002066:Busulfan / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D011087:Polycythemia Vera / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000175:diagnosis; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests; D012140:Respiratory Tract Diseases / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors; D014797:Vital Capacity / Q000187:drug effects
D002066:Busulfan